NULOJIX (belatacept) Patient Assistance Program
Don’t let the cost of brand transplant therapy disrupt your treatment. We help eligible kidney transplant recipients access Nulojix (belatacept) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Nulojix (belatacept) is FDA-approved for the prevention of organ rejection in adult kidney transplant patients, used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids.
- Nulojix is restricted to recipients who are Epstein-Barr virus (EBV) seropositive because EBV-naive recipients have an increased risk of post-transplant lymphoproliferative disorder (PTLD) — this risk is reflected in a boxed warning on the FDA label.
- Without assistance, the list price for an infusion at the standard maintenance schedule is approximately $1,940 per infusion, and an initial-phase infusion at 4 vials runs approximately $3,880; over a year, total infusion costs can reach the mid five figures depending on weight and schedule.
- Through AffordMyPrescriptions, qualifying patients can access Nulojix coverage for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process.
What is Nulojix Prescription Assistance Program?
The Nulojix Prescription Assistance Program is a manufacturer-sponsored initiative that provides Nulojix infusions at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for kidney transplant recipients who are uninsured or underinsured, as well as Medicare Part D beneficiaries who cannot afford specialty biologic infusion therapy.
Navigating the program on your own means dealing with eligibility verification, transplant-team coordination, EBV serostatus documentation, infusion scheduling, and renewal deadlines — all while managing the recovery and ongoing care of a kidney transplant.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing infusion-schedule coordination and annual re-certification — so you focus on protecting your transplant, not paperwork.
Pharmacy Price Comparison
- Without assistance, Nulojix infusions cost roughly $1,940–$3,880 each at retail/specialty pharmacy pricing depending on phase. Pharmacy discount coupons are not a meaningful tool for IV infusion therapy. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Maintenance Infusion (2 vials) | ~$1,940.00 | Save ~$1,870/mo |
| Initial-Phase Infusion (4 vials) | ~$3,880.00 | Save ~$3,810/mo |
Specialty Pharmacy (per vial) | ~$1,500.00 | Save ~$1,430/mo |
| Lower-cost specialty option | ~$955.00 | Save ~$885/mo |
| Annual maintenance total | ~$25,000+ | Save ~$24,000+/yr |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Nulojix Prescription Program?
The Patient Assistance Program is free to apply for and provides Nulojix infusions at little or no medication cost if approved. But the process involves detailed applications, transplant-team coordination, EBV documentation, infusion scheduling, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, infusion scheduling, documentation, and annual re-enrollment — so you focus on protecting your transplant, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Nulojix:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
- Coupon cards expire and require constant renewal
- Still $1,940–$3,880 per month even with the best discount
- Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Nulojix assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Nulojix Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Nulojix:
Nulojix (belatacept) is an intravenous (IV) biologic medicine used to help prevent organ rejection in adults who have received a kidney transplant. It is part of a combination regimen used together with basiliximab induction therapy, mycophenolate mofetil, and corticosteroids, and is given by infusion in a clinic, infusion center, or transplant center setting on a defined schedule. Nulojix is restricted to recipients who are Epstein-Barr virus (EBV) seropositive.
How It Works:
Nulojix is designed to prevent the immune system from rejecting a transplanted kidney by blocking a specific step in T-cell activation called co-stimulation. It acts as a fusion protein that binds to molecules on antigen-presenting cells, physically preventing the second signal required for a full immune response. Without this signal, T cells are less capable of attacking the new organ, which helps protect the transplant.
Form and Use:
This medication is administered exclusively as an intravenous (IV) infusion at a clinic or transplant center rather than at home. Dosing is determined by the patient’s weight, starting with a more frequent schedule of 10 mg/kg during the first few months post-transplant. After 16 weeks, the treatment moves into a maintenance phase, where it is typically given once every four weeks at a dose of 5 mg/kg.
Generic Availability:
As of 2026, there are no FDA-approved biosimilars or generic versions of Nulojix available in the U.S. Because it is a biologic medicine, any future competition would come in the form of a biosimilar, but none have been approved yet. While other transplant regimens like tacrolimus offer generic options, the decision to use Nulojix over these alternatives is a complex clinical choice made by a specialized transplant team.
Warnings:
Nulojix carries a boxed warning for post-transplant lymphoproliferative disorder (PTLD), especially in patients who have not been previously exposed to the Epstein-Barr virus (EBV). Consequently, its use is restricted to recipients who are confirmed to be EBV seropositive. Other serious risks include the potential for severe infections, certain malignancies, and reactions during the infusion process.
FAQ (Frequently Asked Questions)
How Much Does Nulojix Cost Without Insurance?
The list price is approximately $1,940 per maintenance-phase infusion, $3,880 per initial-phase infusion, and approximately $955–$1,500 per individual 250 mg vial. Total annual cost depends on body weight, schedule, and infusion-site billing — commonly reaching the mid five figures. Through AffordMyPrescriptions, qualifying patients receive Nulojix infusions at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Is Nulojix Only Used In EBV-Positive Patients?
EBV-naive recipients (people who have not been exposed to Epstein-Barr virus before transplant) have a meaningfully increased risk of post-transplant lymphoproliferative disorder (PTLD) when they receive Nulojix. For that reason, Nulojix is restricted to recipients who are EBV seropositive, and the transplant team will confirm EBV status before starting therapy.
Are There Other Immunosuppressive Options I Should Know About?
Yes. Most kidney transplant maintenance regimens are based on calcineurin inhibitors such as tacrolimus, which is widely available as a generic at substantially lower medication cost than Nulojix. Whether a calcineurin-based regimen is a better fit for you is a clinical decision that depends on your kidney function, infection risk, and other factors. We mention this directly because if a different regimen on a more accessible cost path would adequately protect your transplant, your transplant team is the right partner to discuss that with
Can I Get Nulojix Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Nulojix Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program (~$50/infusion, up to ~$7,000/year) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria
What if my application is denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent foundations such as the PAN Foundation or HealthWell Foundation for kidney-transplant funds, the American Kidney Fund, the National Kidney Foundation, the manufacturer’s copay assistance program if you have commercial insurance, or asking your transplant team whether a calcineurin-based maintenance regimen on a more accessible cost path would be appropriate. If we cannot find a path to medication access, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients see their first covered Nulojix infusion within two to four weeks of completing the documentation. Timing depends on how quickly your transplant team returns the required forms and the program processes your application.
Take Control of Your Medication Costs
If you are struggling with the high cost of Nulojix, our team may be able to help you access assistance programs designed to make brand transplant therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.